2018

1. Sato T, Shiraishi T, Hiyama Y, Honda H, Shinagawa M, Usui M, Kuronuma K, Masumori N, Takahashi S, Tamura Y, Yokota SI.

Contribution of novel amino acid alterations in PmrA or PmrB to colistin resistance in mcr-negative Escherichia coli clinical isolates including major multidrug-resistant lineages O25b:H4-ST131-H30Rx and non-x.

Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00864-18. doi: 10.1128/AAC.00864-18. [Epub ahead of print]. PMID: 29914952

 

2. Ohkoshi Y, Sato T, Wada T, Fukushima Y, Murabayashi H, Takakuwa Y, Nishiyama K, Honda H, Shiraishi T, Kuronuma K, Takahashi H, Nakajima C, Suzuki Y, Yokota SI.

Whole genome analysis of a multidrug-resistant Streptococcus pneumoniae isolate from a patient with invasive pneumococcal infection developing disseminated intravascular coagulation.

J Infect Chemother. 2018 Aug;24(8):674-681. doi: 10.1016/j.jiac.2018.01.012. Epub 2018 Feb 26.PMID:29496334

 

3. Sato T, Fukuda A, Usui M, Shinagawa M, Shiraishi T, Tamura Y, Takahashi S, Yokota SI.

Isolation of a mcr-1-harbouring Escherichia coli isolate from a human clinical setting in Sapporo, Japan.

J Glob Antimicrob Resist. 2018 Jun;13:20-21. doi: 10.1016/j.jgar.2018.02.010. Epub 2018 Feb 21. PMID:29476984

 

4. Yokota SI, Hakamada H, Yamamoto S, Sato T, Shiraishi T, Shinagawa M, Takahashi S.

Release of large amounts of lipopolysaccharides from Pseudomonas aeruginosa cells reduces their susceptibility to colistin.

Int J Antimicrob Agents. 2018 Jun;51(6):888-896. doi: 10.1016/j.ijantimicag.2018.02.004. Epub 2018 Feb 9.PMID:29432867

 

5. Yamamoto K, Ogasawara N, Yamamoto S, Takano K, Shiraishi T, Sato T, Tsutsumi H, Himi T, Yokota SI.

Evaluation of consistency in quantification of gene copy number by real-time reverse transcription quantitative polymerase chain reaction and virus titer by plaque-forming assay for human respiratory syncytial virus.

Microbiol Immunol. 2018 Feb;62(2):90-98. doi: 10.1111/1348-0421.12563. PMID:29266482

 

6. Fukuda A, Sato T, Shinagawa M, Takahashi S, Asai T, Yokota SI, Usui M, Tamura Y.

High prevalence of mcr-1, mcr-3 and mcr-5 in Escherichia coli derived from diseased pigs in Japan.

Int J Antimicrob Agents. 2018 Jan;51(1):163-164. doi: 10.1016/j.ijantimicag.2017.11.010. Epub 2017 Nov 26. PMID:29180277

 

7. Yamamoto S, Kuramoto K, Wang N, Situ X, Priyadarshini M, Zhang W, Cordoba-Chacon J, Layden BT, He C.

Autophagy differentially regulates insulin production and insulin sensitivity.

Cell Rep. 2018 Jun 12;23(11):3286-3299. doi: 10.1016/j.celrep.2018.05.032. PMID:29898399

 

8. Sato T, Harada K, Usui M, Tsuyuki Y, Shiraishi T, Tamura Y, Yokota SI. 

Tigecycline Susceptibility of Klebsiella pneumoniae Complex and Escherichia coli Isolates from Companion Animals: The Prevalence of Tigecycline-Nonsusceptible K. pneumoniae Complex, Including Internationally Expanding Human Pathogenic Lineages.

Microb Drug Resist. 2018 Jul/Aug;24(6):860-867. doi: 10.1089/mdr.2017.0184. Epub 2017 Dec 12. PMID: 29232167

 

9. Honda H, Sato T, Shinagawa M, Fukushima Y, Nakajima C, Suzuki Y, Shiraishi T, Kuronuma K, Takahashi S, Takahashi H, Yokota SI.

Multiclonal expansion and high prevalence of β-lactamase-negative high-level ampicillin-resistant Haemophilus influenzae in Japan, and susceptibility to quinolones. Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00851-18. doi: 10.1128/AAC.00851-18. [Epub ahead of print] PMID:29987153

 

10. Kuronuma K, Honda H, Mikami T, Saito A, Ikeda K, Otsuka M, Chiba H, Yamada G, Sato T, Yokota SI, Takahashi H. 

Response to pneumococcal vaccine in interstitial lung disease patients: Influence of systemic immunosuppressive treatment.

Vaccine. 2018 Jul 5. pii: S0264-410X(18)30903-4. doi: 10.1016/j.Vaccine.2018.06.062. [Epub ahead of print] PMID:29983256

 

11. Ogasawara N, Poposki JA, Klingler AI, Tan BK, Weibman AR, Hulse KE, Stevens WW, Peters AT, Grammer LC, Schleimer RP, Welch KC, Smith SS, Conley DB, Raviv JR, Soroosh P, Akbari O, Himi T, Kern RC, Kato A. IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells. J Allergy Clin Immunol. 2018 Mar;141(3):1147-1151. PMID:29122495

 

12. Ogasawara N, Klingler AI, Tan BK, Poposki JA, Hulse KE, Stevens WW, Peters AT, Grammer LC, Welch KC, Smith SS, Conley DB, Kern RC, Schleimer RP, Kato A. Epithelial activators of type 2 inflammation; elevation of TSLP, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois. Allergy. 2018 PMID:29987901

 

13. Nakamura H, Akashi K, Watanabe M, Ohta S, Ono J, Azuma Y, Ogasawara N, Yamamoto K, Shimizu N, Tsutsumi H, Izuhara K, Katsunuma T. Up-regulation of serum periostin and squamous cell carcinoma antigen levels in infants with acute bronchitis due to respiratory syncytial virus. Allergol Int. 2018 Apr;67(2):259-265. PMID:29122495

 

2017

1. Sato T, Suzuki Y, Shiraishi T, Honda H, Shinagawa M, Yamamoto S, Ogasawara N, Takahashi H, Takahashi S, Tamura Y, Yokota SI.

Tigecycline nonsusceptibility occurs exclusively in fluoroquinolone-resistant Escherichia coli clinical isolates, including the major multidrug-resistant lineages O25b:H4-ST131-H30R and O1-ST648.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01654-16. doi: 10.1128/AAC.01654-16. Print 2017 Feb. PMID: 27855067

 

2. Uemura S, Yokota SI, Shiraishi T, Kitagawa M, Hirayama S, Kyan R, Mizuno H, Sawamoto K, Inoue H, Miyamoto A, Narimatsu E.

Adaptive cross-resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa induced by topical dosage of neomycin.

Chemotherapy. 2017;62(2):121-127. doi: 10.1159/000449368. Epub 2016 Oct 29. PMID: 27794569

 

3. Yamamoto S, Ogasawara N, Yamamoto K, Uemura C, Takaya Y, Shiraishi T, Sato T, Hashimoto S, Tsutsumi H, Takano K, Himi T, Yokota SI.

Mitochondrial proteins NIP-SNAP-1 and -2are a target for the immunomodulatory activity of clarithromycin, which involves NF-κB-mediated cytokine production. 

Biochem Biophys Res Commun. 2017 Feb 12;483(3):911-916. doi: 10.1016/j.bbrc.2016.12.100. Epub 2016 Dec 18. PMID: 27998764

 

4. Yamamoto S, Okamoto T, Ogasawara N, Hashimoto S, Shiraishi T, Sato T, Yamamoto K,Tsutsumi H, Takano K, Himi T, Itoh H, YokotaSI.

NIP-SNAP-1 and -2 mitochondrial proteins are maintained by heat shock protein 60.

Biochem Biophys Res Commun. 2017Feb 12;483(3):917-922. doi: 10.1016/j.bbrc.2016.12.133.Epub 2016 Dec 21.PMID:28011268

 

5. Ohkoshi Y, Sato T, Suzuki Y, Yamamoto S, Shiraishi T, Ogasawara N, Yokota SI.

Mechanism of reduced susceptibility to fosfomycin in Escherichia coli clinical isolates.

Biomed Res Int. 2017;2017:5470241. doi: 10.1155/2017/5470241. Epub 2017 Jan 19. PMID: 28197413

 

6. Sato Y, Koshizuka T, Ishibashi K, Hashimoto K, Ishioka K, Ikuta K, YokotaSI, Fujii N, Suzutani T.

Involvement of herpes simplex virus type 1 UL13 protein kinase in induction of SOCS genes, the negative regulators of cytokine signaling.

Microbiol Immunol. 2017May;61(5):159-167. doi: 10.1111/1348-0421.12483. PMID:28419615

 

7. Sato T, Higuchi H, Yokota SI, Tamura Y.

Mycoplasma bovis isolates from dairy calves in Japan have less susceptibility than a reference strain to all approved macrolides associated with a point mutation (G748A) combined with multiple species-specific nucleotide alterations in 23S rRNA.

Microbiol Immunol. 2017 Jun;61(6):215-224. doi: 10.1111/1348-0421.12490. PMID: 28504455

 

8. Kitagawa M, Shiraishi T, Yamamoto S, Kutomi R, Ohkoshi Y, Sato T, Wakui H, Itoh H, Miyamoto A, Yokota SI.

Novel antimicrobial activities of a peptide derived from a Japanese soybean fermented food, Natto, against Streptococcus pneumoniae and Bacillus subtilis group strains.

AMB Express. 2017 Dec;7(1):127. doi: 10.1186/s13568-017-0430-1. Epub 2017 Jun 20.PMID: 28641406

 

9. Rocchi A, Yamamoto S, Ting T, Fan Y, Sadleir K, Wang Y, Zhang W, Huang S, Levine B,Vassar R, He C, A.

Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer's disease.

PLoS Genet 2017;13(8):e1006962

 

10. Kaneko Y, Kohno T, Kakui T, Takano K, Ogasawara N, Miyata R,Kikuchi S, Konno T, Ohkuni T, Yajima R, Kakiuchi A, Yokota S, Himi T, Kojima T.

The role of transcriptional factor p63 in regulation of epithelial barrier and ciliogenesis of human nasal epithelial cells.

Sci Rep. 2017 Sep 7;7(1):10935. doi: 10.1038/s41598-017-11481-w. PMID:83651

 

11. Sato T, Ohkoshi Y, Wada T, Fukushima Y, Murabayashi H, Takakuwa Y, Nishiyama K, Shiraishi T, Nakajima C, Suzuki Y, Yokota SI.

Complete genome sequence of multidrug-resistant Streptococcus pneumoniae 19F isolated from an invasive infection in Sapporo, Japan.

Genome Announc. 2017 Nov 2;5(44). pii: e01239-17. doi: 10.1128/genomeA.01239-17. PMID: 29097473

 

12. Kamekura R, Takano K, Yamamoto M, Kawata K, Shigehara K, Jitsukawa S, Nagaya T, Ito F, Sato A, Ogasawara N, Tsubomatsu C, Takahashi H, Nakase H, Himi T, Ichimiya S.

Cutting Edge: A critical role of lesional T follicular helper cells in the pathogenesis of IgG4-related disease.

J Immunol. 2017 Oct 15;199(8):2624-2629. doi: 10.4049/jimmunol.1601507. Epub 2017 Sep 15. PMID:28916523

 

13. Kojima T, Kohno T, Kubo T, Kaneko Y, Kakuki T, Kakiuchi A, Kurose M, Takano KI, Ogasawara N, Obata K, Nomura K, Miyata R, Konno T, Ichimiya S, Himi T.

Regulation of claudin-4 via p63 in human epithelial cells.

Ann N Y Acad Sci. 2017 Oct;1405(1):25-31. doi: 10.1111/nyas.13456. Epub 2017 Aug 30. Review. PMID:28856683

 

○その他論文(2017年)

 

1.白石宗,横田伸一,吹谷智,横田篤.

特集:乳酸菌が持つ新たな微生物機構の解明とそ の利用リポテイコ酸の構造多様性から見える乳酸菌の特徴.

JATAFFジャーナル2017; 5(3):26-32.

 

2.横田伸一,佐藤豊孝.

抗菌薬多剤耐性におけるefflux pumpの役割を見直す.

化学療法の領域2017; 33(8):1698-1703.

 

3.白石宗,北川学,山本聡,久富亮佑,佐藤豊孝,涌井秀樹,伊藤英晃,宮本篤,横田伸 一.

納豆由来ペプチドの特異な殺菌効果とその作用機序.エンドトキシン・自然免疫研究 20-自然免疫における化学生物学の貢献-(日本エンドトキシン・自然免疫研究会編).

医学図書出版,東京,2017.pp.39-42.

 

4.山本圭佑,小笠原徳子,山本聡,堤裕幸,氷見徹夫,横田伸一.

クラリスロマイシンは 気道上皮細胞でRSウイルスによって誘導されるインターフェロンの産生をIRF-3を介して 調整する.

Jpn J Antibiot 2017;70(suppl. A):19-24.

 

5.横田伸一,山本聡,小笠原徳子,植村知加,高谷芳明,伊藤英晃,山本圭佑,白石宗, 佐藤豊孝,氷見徹夫.

クラリスロマイシンの炎症反応修飾作用の分子機構の解明―気道上 皮細胞のクラリスロマイシン結合タンパク質の同定と機能解明―.

Jpn J Antibiot 2017;70(suppl. A):60-64.

 

6.小笠原徳子, 品川雅明, 高野賢一, 坪松ちえ子, 氷見徹夫. 

【臨床力UP!耳鼻咽喉科検査マニュアル】

細菌ウイルス検査抗酸菌に関する検査耳鼻咽喉科・頭頸部外科2017; 89(5):432-435.

 

7.白石宗,横田伸一,吹谷智,横田篤.

ミニ特集24:微生物の多様性構造情報の蓄積から見えてきたリポテイコ酸の細菌種による構造多様性.

日本乳酸菌学会誌2017;28(3):177.

 

8.戸板成昭,藤原伸一,高橋美智子,今野武津子,横田伸一.

家族内発症のCrohn 病3家 系7症例における臨床的特徴の比較検討ならびに疾患関連遺伝子(TNFSF15)の解析.

臨牀小児医学 2017;65(1-6): 11-14. 

 

 

2016

1. Hashimoto S, Yamamoto S, Ogasawara N, Sato T, Yamamoto K, Katoh H, Kubota T, Shiraishi T, Kojima T, Himi T, Tsutsumi H, Yokota S.

Mumps virus induces protein-kinase-R-dependent stress granules, partly suppressing type III interferon production.

PLoS One. 2016 Aug 25;11(8):e0161793. doi: 10.1371/journal.pone.0161793. PMID: 27560627

 

 2. Yamamoto K, Yamamoto S, Ogasawara N, Takano K, Shiraishi T, Sato T, Miyata R, Kakuki T, Kamekura R, Kojima T, Tsutsumi H, Himi T, Yokota S.

Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3.

Pharmacol Res. 2016 Sep;111:804-14. doi: 10.1016/j.phrs.2016.07.033.PMID: 27468646

 

3. Jinushi M, Yamamoto S, Ogasawara N, Nagano H, Hashimoto S, Tsutsumi H, Himi T, Yokota S.

Measles virus genotype D wild strains suppress interferon-stimulated gene expression more potently than laboratory strains in SiHa cells.

Viral Immunol. 2016 Jun;29(5):296-306. doi: 10.1089/vim.2016.0004.PMID: 27035543

 

4. Sato T, Fukuda A, Suzuki Y, Shiraishi T, Honda H, Shinagawa M, Yamamoto S,  Ogasawara N, Usui M,Takahashi H, Takahashi S, Tamura Y, Yokota S. 

Pathogenic lineage of mcr-negative colistin-resistant Escherichia coli, Japan, 2008-2015 

Emerg Infect Dis.2016 Dec;22(12):2223-2225.doi:10.3201/eid2212.161117. PMID:27869606

 

5. Shiraishi T, Yokota S, Fukiya S, Yokota A.

Structural diversity and biological significance of lipoteichoic acid in Gram-positive bacteria:focusing on beneficial probiotic lactic acid bacteria.

Biosci Microbiata Food Health. 2016;35(4):147-161.Review. PMID:27867802

 

○その他論文(2016 年)

1. 横田伸一

抗菌薬耐性菌の驚くべき進化と脅威 

日本耳鼻咽喉科感染症・エアロゾル学会会誌、2016;4(1):6-13

 

2. 小笠原徳子、高野賢一、氷見徹夫

微生物学的検査のピットフォール 的確な感染症診断 耳鼻咽喉科領域における結核菌感染症(総説)

日本耳鼻咽喉科感染症・エアロゾル学会会誌 2016;4(2):77-81

 

3. 白石 宗、佐藤 耶舞羽、横田伸一、伊藤利章、吹谷智、横田篤

Lactobacillus gasseri JCM1131T の対数期におけるリポテイコ酸の局在: Membrane vesicle 表層に露出されるリポテイコ酸

エンドトキシン・自然免疫研究19-新たなる基礎と臨床の架け橋-(日本エンドトキシン・自然免疫研究会編).医学図書出版,東京,2016.pp. 15-17.

 

 

2015

 

 1. Yokota S, Konno M, Fujiwara S, Toita N, Takahashi M, Yamamoto S, Ogasawara N, Shiraishi T.

Intrafamilial, preferentially mother-to-child and intraspousal, Helicobacter pylori infection in Japan determined by mutilocus sequence typing and random amplified polymorphic DNA fingerprinting.

Helicobacter. 2015 Oct;20(5):334-42. doi: 10.1111/hel.12217. Epub 2015 Feb 9.

 

2.Grave E, Yokota S, Yamamoto S, Tamura A, Ohtaki-Mizoguchi T, Yokota K, Oguma K, Fujiwara K, Ogawa N, Okamoto T, Otaka M, Itoh H.

Geranylgeranylacetone selectively binds to the HSP70 of Helicobacter pylori and alters its coccoid morphology.

Sci Rep. 2015 Sep 8;5:13738. doi: 10.1038/srep13738.

 

3.Takano K, Kaizaki A, Saikawa E, Konnno A, Ogasawara N, Himi T.

Outcomes of visually impaired patients who received cochlear implantations.

Auris Nasus Larynx. 2015 Sep 17. pii: S0385-8146(15)00199-6. doi: 10.1016/j.anl.2015.08.005.

 

4.Yamamoto K, Ogasawara N, Seki N, Konno N, Tsubota H, Himi T.

Vascular tumors of the external auditory canal: three case reports and a review of the literature

Springerplus. 2015 Jul 1;4:307. doi: 10.1186/s40064-015-1113-5. eCollection 2015.

 

5.Miyata R, Kakuki T, Nomura K, Ohkuni T, Ogasawara N, Takano K, Konno T, Kohno T, Sawada N, Himi T, Kojima T.

Poly(I:C) induced microRNA-146a regulates epithelial barrier and secretion of proinflammatory cytokines in human nasal epithelial cells.

Eur J Pharmacol. 2015 Aug 15;761:375-82. doi: 10.1016/j.ejphar.2015.04.031. Epub 2015 May 7.

 

6.Kamekura R, Shigehara K, Miyajima S, Jitsukawa S, Kawata K, Yamashita K, Nagaya T, Kumagai A, Sato A, Matsumiya H, Ogasawara N, Seki N, Takano K, Kokai Y, Takahashi H, Himi T, Ichimiya S.

Alteration of circulating type 2 follicular helper T cells and regulatory B cells underlies the comorbid association of allergic rhinitis with bronchial asthma.

Clin Immunol. 2015 Jun;158(2):204-11. doi: 10.1016/j.clim.2015.02.016. Epub 2015 Mr 28.

 

 ○その他論文(2015 年)

1. 横田伸一,今野武津子.

ヘリコバクター・ピロリ感染症と鉄欠乏性貧血

臨床と微生物 2015; 42:165-170.

 

2. 小笠原徳子,横田伸一,山本圭祐,橋本真,堤裕幸,氷見徹夫.

最新動向から見直す呼吸器感染症マネジメント ウイルス性呼吸器感染症―冬期の RS ウイルス流行に備えて.

感染と抗菌薬 2015; 18:242-246.

 

3. 白石宗,横田伸一,吹谷智,横田篤

腸内乳酸菌 Lactobacillus gasseri JCM 1131T のリポテイコ酸に認められた新奇構造.

エンドトキシン・自然免疫研究 18-自然免疫における生体防御ペプチドの多様性-(日本エンドトキシ ン研究会編).

医学図書出版,東京,2015.pp. 79-81.

 

4. 小笠原徳子,才川悦子,高野賢一,新谷朋子,氷見徹夫

当科における人工内耳埋め込み術の術後合併症に関する検討

Otology Japan 25(1): 51-57, 2015 

 

  

2014

 

1.Yamamoto S, Wakui H, Kubota H, Komatsuda A, Itoh H, Yokota S.

Aminoglycosides suppress the protein folding activity of the molecular chaperone HSC70: Implication of a structure-activity relationship.

Chemotherapy. 2014;60(1):37-46. doi: 10.1159/000365880. Epub 2014 Oct 29.

 

2. Alvira S, Cuéllar J, Röhl A, Yamamoto S, Itoh H, Alfonso C, Rivas G, Buchner J, Valpuesta JM.

Structural characterization of the substrate transfer mechanism in Hsp70/Hsp90 folding machinery mediated by Hop.

Nat Commun. 2014 Nov 19;5:5484. doi: 10.1038/ncomms6484.

 

3.Sato T, Okubo T, Usui M, Yokota S, Izumiyama S, Tamura Y.

Association of veterinary third-generation cephalosporin use with the risk of emergence of extended-spectrum-cephalosporin resistance in Escherichia coli from dairy cattle in Japan. PLoS One. 2014 Apr 22;9(4):e96101. doi: 10.1371/journal.pone.0096101. eCollection 2014.

 

4.Okubo T, Sato T, Yokota S, Usui M, Tamura Y.

Comparison of broad-spectrum cephalosporin-resistant Escherichia coli isolated from dogs and humans in Hokkaido, Japan.

J Infect Chemother. 2014 Apr;20(4):243-9. doi: 10.1016/j.jiac.2013.12.003. Epub 2014 Jan 24

 

5.Kakugawa T, Yokota S, Ishimatsu Y, Hayashi T, Nakashima S, Hara S, Sakamoto N, Kubota H, Mine M, Matsuoka Y, Mukae H, Nagata K, Kohno S.

Serum heat shock protein 47 levels are elevated in acute interstitial pneumonia.

BMC Pulm Med. 2014 Mar 21;14:48. doi: 10.1186/1471-2466-14-48.

 

6.Sato T, Yokota S, Ichihashi R, Miyauchi T, Okubo T, Usui M, Fujii N, Tamura Y.

Isolation of Escherichia coli strains with AcrAB-TolC efflux pump-associated intermediate interpretation or resistance to fluoroquinolone, chloramphenicol and aminopenicillin from dogs admitted to a university veterinary hospital.

J Vet Med Sci. 2014 Jul;76(7):937-45. Epub 2014 Mar 18.

 

7.Yamamoto S, Subedi GP, Hanashima S, Satoh T, Otaka M, Wakui H, Sawada K, Yokota S, Yamaguchi Y, Kubota H, Itoh H.

ATPase activity and ATP-dependent conformational change in the co-chaperone HSP70/HSP90-organizing protein (HOP).

J Biol Chem. 2014 Apr 4;289(14):9880-6. doi: 10.1074/jbc.M114.553255. Epub 2014 Feb 17.

 

8.Sato T, Yokota S, Okubo T, Usui M, Fujii N, Tamura Y.

Phylogenetic association of fluoroquinolone and cephalosporin resistance of D-O1-ST648 Escherichia coli carrying blaCMY-2 from faecal samples of dogs in Japan.

J Med Microbiol. 2014 Feb;63(Pt 2):263-70. doi: 10.1099/jmm.0.054676-0. Epub 2013 Feb 21.

 

9.Takano K, Saikawa E, Ogasawara N, Himi T.

Cochlear implantation in a patient with Paget's disease.

Am J Otolaryngol. 2014 May-Jun;35(3):408-10. doi:10.1016/j.amjoto.2014.02.011. Epub 2014 Feb 28. PubMed PMID: 24636914.

 

10.Tsuji N, Fukuda K, Nagata Y, Okada H, Haga A, Hatakeyama S, Yoshida S, Okamoto T, Hosaka M, Sekine K, Ohtaka K, Yamamoto S, Otaka M, Grave E, Itoh H.

The activation mechanism of the aryl hydrocarbon receptor (AhR) by molecular chaperone HSP90.

FEBS Open Bio. 2014 Sep 16;4:796-803. doi: 10.1016/j.fob.2014.09.003. eCollection 2014. 

 

○その他論文(2014)

1.今野武津子,横田伸一,高橋美智子,藤原伸一,大崎敬子,神谷茂

日本人小児の最近のピロリ菌感染率と感染経路について

日本ヘリコバクター学会誌 2014: 15 (2); 68-74

 

2.横田伸一,堤裕幸,氷見徹夫

RS ウイルス感染症に対するマクロライドの可能性

Jpn J Antibiot. 2014: 67(3):147-155

 

3.氷見徹夫,高野賢一,大國毅,小笠原徳子,山本圭佑,高橋希

上気道粘膜とウイルス感染

JOHNS 2014: 30(11)1533-1539

 

4.氷見徹夫,高野賢一,大國毅,小笠原徳子,正木智之,小幡和史,堤裕幸,小島隆,澤田 典均,横田伸一

ウイルス性炎症における上気道粘膜の役割 鼻粘膜上皮機能解析から炎症制御戦略を探る

日本耳鼻咽喉科感染症・エアロゾル学会会誌 2014: 2(1) 1-5

 

5.小笠原徳子,横田伸一,氷見徹夫

ウイルス性呼吸器感染症 RS ウイルス・ライノウイルス

感染と抗菌薬 2014: 17(1) 68-72

 

6.高野賢一,大國毅,小笠原徳子,氷見徹夫

アブミ骨固着症例の検討

耳鼻咽喉科・頭頸部外科 2014: 86(2) 171-177

 

7.松田三千雄,山本聡,岡林環樹 排膿散及湯はインターフェロン産生誘導薬か?

漢方医学 2014:38(2) 123-126 

 

 

2013

 

1.Tsukamoto N, Ohkoshi Y, Okubo T, Sato T, Kuwahara O, Fujii N, Tamura Y, Yokota S. High prevalence of cross-resistance to aminoglycosides in fluoroquinolone-resistant Escherichia coli clinical isolates  

Chemotherapy. 2013;59(5):379-84. doi: 10.1159/000361011. Epub 2014 May 13.

 

2.Obata K, Kojima T, Masaki T, Okabayashi T, Yokota S, Hirakawa S, Nomura K, Takasawa A, Murata M, Tanaka S, Fuchimoto J, Fujii N, Tsutsumi H, Himi T, Sawada N.

Curcumin prevents replication of respiratory syncytial virus and the epithelial responses to it in human nasal epithelial cells.

PLoS One. 2013 Sep 18;8(9):e70225. doi: 10.1371/journal.pone.0070225.

 

3.Hirakawa S, Kojima T, Obata K, Okabayashi T, Yokota S, Nomura K, Obonai T, Fuchimoto J, Himi T, Tsutsumi H, Sawada N.

Marked induction of matrix metalloproteinase-10 by respiratory syncytial virus infection in human nasal epithelial cells.

J Med Virol. 2013 Dec;85(12):2141-50. doi: 10.1002/jmv.23718. Epub 2013 Sep 5.

 

4.Yokota S, Toita N, Yamamoto S, Fujii N, Konno M.

Positive relationship between a polymorphism in Helicobacter pylori neutrophil-activating protein a gene and iron-deficiency anemia.

Helicobacter. 2013 Apr;18(2):112-6. doi: 10.1111/hel.12011. Epub 2012 Oct 3.

 

5.Kojima T, Go M, Takano K, Kurose M, Ohkuni T, Koizumi J, Kamekura R, Ogasawara N, Masaki T, Fuchimoto J, Obata K, Hirakawa S, Nomura K, Keira T, Miyata R, Fujii N, Tsutsumi H, Himi T, Sawada N.

Regulation of tight junctions in upper airway epithelium.

Biomed Res Int. 2013;2013:947072. doi: 10.1155/2013/947072. Epub 2012 Dec 29.

 

6.Toita N, Yokota S, Fujii N, Konno M.

Clonality analysis of Helicobacter pylori in patients isolated from several biopsy specimens and gastric juice in a Japanese urban population by random amplified polymorphic DNA fingerprinting.

Gastroenterol Res Pract. 2013;2013:721306. doi: 10.1155/2013/721306. Epub 2013 Nov 17.

 

7.Shiraishi T, Yokota S, Morita N, Fukiya S, Tomita S, Tanaka N, Okada S, Yokota A.

Characterization of a Lactobacillus gasseri JCM 1131T lipoteichoic acid with a novel glycolipid anchor structure.

Appl Environ Microbiol. 2013 May;79(10):3315-8. doi: 10.1128/AEM.00243-13. Epub 2013 Mar 15.

 

8.Sato T, Yokota S, Okubo T, Ishihara K, Ueno H, Muramatsu Y, Fujii N, Tamura Y.

Contribution of the AcrAB-TolC efflux pump to high-level fluoroquinolone resistance in Escherichia coli isolated from dogs and humans.

J Vet Med Sci. 2013 May 2;75(4):407-14. Epub 2012 Nov 14.

 

 9.Sato T, Yokota S, Uchida I, Okubo T, Usui M, Kusumoto M, Akiba M, Fujii N, Tamura Y.

Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations.

Front Microbiol. 2013 May 24;4:125. doi: 10.3389/fmicb.2013.00125. eCollection 2013.

 

10.Kakugawa T, Yokota S, Ishimatsu Y, Hayashi T, Nakashima S, Hara S, Sakamoto N, Kubota H, Mine M, Matsuoka Y, Mukae H, Nagata K, Kohno S.

Serum heat shock protein 47 levels are elevated in acute exacerbation of idiopathic pulmonary fibrosis.

Cell Stress Chaperones. 2013 Sep;18(5):581-90. doi: 10.1007/s12192-013-0411-5. Epub 2013 Feb 22.

 

11.Kakugawa T, Yokota S, Ishimatsu Y, Hayashi T, Nakashima S, Hara S, Sakamoto N, Matsuoka Y, Kubota H, Mine M, Mukae H, Nagata K, Kohno S.

Serum heat shock protein 47 levels in patients with drug-induced lung disease.

Respir Res. 2013 Nov 20;14:133. doi: 10.1186/1465-9921-14-133.

 

12.Fuchimoto J, Kojima T, Okabayashi T, Masaki T, Ogasawara N, Obata K, Nomura K, Hirakawa S, Kobayashi N, Shigyo T, Yokota S, Fujii N, Tsutsumi H, Himi T, Sawada N.

Humulone suppresses replication of respiratory syncytial virus and release of IL-8 and RANTES in normal human nasal epithelial cells.

Med Mol Morphol. 2013 Dec;46(4):203-9. doi: 10.1007/s00795-013-0024-1. Epub 2013 Feb 5.

 

○その他論文(2013年)

1.Ogasawara N, Kikuchi K, Yoshioka I, Yamashita K, Himi T.

Solitary fibrous tumor of the head and neck in a child.(Case report and review of the literature. J Pediatr Surg Case Rep 1(8) 194-196,2013)